Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
European Journal of Medicinal Chemistry
|
June 24, 2026
Pyrazinamide-derived 1,2,3-triazoles: Antimicrobial evaluation, selective antimycobacterial activity and mechanism of action insights
Priam-Amedeo Houngbedji, Andrea Bachtíková, Jarmila Boháčová, et al.
European Journal of Medicinal Chemistry
|
January 3, 2024
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus
Matteo Mori, Mario Cocorullo, Andrea Tresoldi, et al.
Molecular Systems Biology
|
May 25, 2021
From coarse to fine: the absolute Escherichia coli proteome under diverse growth conditions
Matteo Mori, Zhongge Zhang, Amir Banaei-Esfahani, et al.
Chemmedchem
|
April 16, 2025
Novel Quinazolinones Active against Multidrug-Resistant Mycobacterium Tuberculosis: Synthesis, Antimicrobial Evaluation, and in Silico Exploration of Penicillin-Binding Protein 1A as a Potential Target
Marek Kerda, Daria Nawrot, Petr Slechta, et al.
European Journal of Medicinal Chemistry
|
June 26, 2018
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents
Laurent R Chiarelli, Matteo Mori, Daniela Barlocco, et al.
Chemmedchem
|
August 29, 2025
Investigating the Mechanism of Antimycobacterial and Antiproliferative Activity of (E)-N'-Benzylidenepyrazine-2-Carbohydrazides and their Derivatives
Priam-Amedeo Houngbedji, Daria Elżbieta Nawrot, Ondřej Janďourek, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
March 21, 2019
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents
Laurent R Chiarelli, Matteo Mori, Giangiacomo Beretta, et al.
Pharmaceutics
|
February 25, 2023
Targeting Siderophore-Mediated Iron Uptake in <i>M. abscessus</i>: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria
Matteo Mori, Giovanni Stelitano, Giulia Cazzaniga, et al.
Archiv Der Pharmazie
|
May 6, 2024
A hit expansion of 3-benzamidopyrazine-2-carboxamide: Toward inhibitors of prolyl-tRNA synthetase with antimycobacterial activity
Vinod Sukanth Kumar Pallabothula, Nechirwan Taimur Abdalrahman, Matteo Mori, et al.
Journal of Medicinal Chemistry
|
March 3, 2025
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy
Giulia Cazzaniga, Matteo Mori, Anna Griego, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
European Journal of Medicinal Chemistry
|
June 24, 2026
Pyrazinamide-derived 1,2,3-triazoles: Antimicrobial evaluation, selective antimycobacterial activity and mechanism of action insights
Priam-Amedeo Houngbedji, Andrea Bachtíková, Jarmila Boháčová, et al.
European Journal of Medicinal Chemistry
|
January 3, 2024
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus
Matteo Mori, Mario Cocorullo, Andrea Tresoldi, et al.
Molecular Systems Biology
|
May 25, 2021
From coarse to fine: the absolute Escherichia coli proteome under diverse growth conditions
Matteo Mori, Zhongge Zhang, Amir Banaei-Esfahani, et al.
Chemmedchem
|
April 16, 2025
Novel Quinazolinones Active against Multidrug-Resistant Mycobacterium Tuberculosis: Synthesis, Antimicrobial Evaluation, and in Silico Exploration of Penicillin-Binding Protein 1A as a Potential Target
Marek Kerda, Daria Nawrot, Petr Slechta, et al.
European Journal of Medicinal Chemistry
|
June 26, 2018
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents
Laurent R Chiarelli, Matteo Mori, Daniela Barlocco, et al.
Chemmedchem
|
August 29, 2025
Investigating the Mechanism of Antimycobacterial and Antiproliferative Activity of (E)-N'-Benzylidenepyrazine-2-Carbohydrazides and their Derivatives
Priam-Amedeo Houngbedji, Daria Elżbieta Nawrot, Ondřej Janďourek, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
March 21, 2019
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents
Laurent R Chiarelli, Matteo Mori, Giangiacomo Beretta, et al.
Pharmaceutics
|
February 25, 2023
Targeting Siderophore-Mediated Iron Uptake in <i>M. abscessus</i>: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria
Matteo Mori, Giovanni Stelitano, Giulia Cazzaniga, et al.
Archiv Der Pharmazie
|
May 6, 2024
A hit expansion of 3-benzamidopyrazine-2-carboxamide: Toward inhibitors of prolyl-tRNA synthetase with antimycobacterial activity
Vinod Sukanth Kumar Pallabothula, Nechirwan Taimur Abdalrahman, Matteo Mori, et al.
Journal of Medicinal Chemistry
|
March 3, 2025
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy
Giulia Cazzaniga, Matteo Mori, Anna Griego, et al.
Page
of 6